Literature DB >> 1508308

Ventricular injection of nerve growth factor increases dopamine content in the striata of MPTP-treated mice.

E Garcia1, C Rios, J Sotelo.   

Abstract

Experimental depletion of dopaminergic striatal neurons was induced in mice with the neurotoxin MPTP. To investigate a possible effect of nerve growth factor on the damaged neurons, we injected 4 micrograms into the right cerebral ventricle of mice three days after the last administration of MPTP. We found a significant increase of dopamine and homovanillic acid in the striatum of MPTP treated mice after NGF administration when compared with dopamine and HVA levels in MPTP-treated control mice (p less than 0.001). The increase of dopamine and homovanillic acid seems to be related to a partial restorative effect of NGF on the damaged dopaminergic cells, since ventricular administration of NGF to normal mice did not increase dopamine or homovanillic acid contents above the levels measured in untreated controls. It appears that administration of nerve growth factor produces a beneficial effect on damaged dopaminergic neurons; this effect could be due to stimulation of neuron sprouting from neurons that survived the toxic effect of MPTP. The increase of dopamine levels was seen 8 days after injection of nerve growth factor and was maintained at least until day 25, showing a lasting persistence of the restorative effect.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508308     DOI: 10.1007/bf00966824

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  20 in total

1.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

Authors:  T J HALEY; W G MCCORMICK
Journal:  Br J Pharmacol Chemother       Date:  1957-03

Review 2.  Cell implantation in Parkinson's disease.

Authors:  A Williams
Journal:  BMJ       Date:  1990-08-11

3.  Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats.

Authors:  T Hama; M Miyamoto; H Tsukui; C Nishio; H Hatanaka
Journal:  Neurosci Lett       Date:  1989-10-09       Impact factor: 3.046

4.  Brain-derived neurotrophic factor prevents neuronal death in vivo.

Authors:  M M Hofer; Y A Barde
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

5.  Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up.

Authors:  O Lindvall; S Rehncrona; P Brundin; B Gustavii; B Astedt; H Widner; T Lindholm; A Björklund; K L Leenders; J C Rothwell; R Frackowiak; D Marsden; B Johnels; G Steg; R Freedman; B J Hoffer; A Seiger; M Bygdeman; I Strömberg; L Olson
Journal:  Arch Neurol       Date:  1989-06

6.  A cell line producing recombinant nerve growth factor evokes growth responses in intrinsic and grafted central cholinergic neurons.

Authors:  P Ernfors; T Ebendal; L Olson; P Mouton; I Strömberg; H Persson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice.

Authors:  R E Heikkila; F S Cabbat; L Manzino; R C Duvoisin
Journal:  Neuropharmacology       Date:  1984-06       Impact factor: 5.250

8.  Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice.

Authors:  D Otto; K Unsicker
Journal:  J Neurosci       Date:  1990-06       Impact factor: 6.167

9.  Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression.

Authors:  M B Rosenberg; T Friedmann; R C Robertson; M Tuszynski; J A Wolff; X O Breakefield; F H Gage
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

10.  Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse.

Authors:  H Hallman; J Lange; L Olson; I Strömberg; G Jonsson
Journal:  J Neurochem       Date:  1985-01       Impact factor: 5.372

View more
  8 in total

1.  Antioxidant effect of Spirulina (Arthrospira) maxima in a neurotoxic model caused by 6-OHDA in the rat striatum.

Authors:  J C Tobón-Velasco; Victoria Palafox-Sánchez; Liliana Mendieta; E García; A Santamaría; G Chamorro-Cevallos; I Daniel Limón
Journal:  J Neural Transm (Vienna)       Date:  2013-02-21       Impact factor: 3.575

2.  URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors.

Authors:  Angel Escamilla-Ramírez; Esperanza García; Guadalupe Palencia-Hernández; Ana Laura Colín-González; Sonia Galván-Arzate; Isaac Túnez; Julio Sotelo; Abel Santamaría
Journal:  Neurotox Res       Date:  2017-01-14       Impact factor: 3.911

Review 3.  Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Authors:  Tiago Martins Rodrigues; André Jerónimo-Santos; Tiago Fleming Outeiro; Ana Maria Sebastião; Maria José Diógenes
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

4.  Electroconvulsive shock does not modify striatal contents of dopamine in MPTP-treated mice.

Authors:  E Garcia; J Sotelo
Journal:  Neurochem Res       Date:  1993-05       Impact factor: 3.996

5.  Short-term manganese pretreatment partially protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

Authors:  P Rojas; C Ríos
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

6.  Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models.

Authors:  J P Steiner; G S Hamilton; D T Ross; H L Valentine; H Guo; M A Connolly; S Liang; C Ramsey; J H Li; W Huang; P Howorth; R Soni; M Fuller; H Sauer; A C Nowotnik; P D Suzdak
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

7.  Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson's Disease Model.

Authors:  Perla Ugalde-Muñiz; Ingrid Fetter-Pruneda; Luz Navarro; Esperanza García; Anahí Chavarría
Journal:  Oxid Med Cell Longev       Date:  2020-01-13       Impact factor: 6.543

Review 8.  Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice.

Authors:  Venissa Machado; Tanja Zöller; Abdelraheim Attaai; Björn Spittau
Journal:  Int J Mol Sci       Date:  2016-01-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.